基于代谢组学的姜黄、郁金寒热药性差异研究
|
摘要
药性是中药的基础和核心,一直是中医药研究的热点和难点。中药药性作为中药的重要特征,是对中药化学成分作用于人体后产生的多种医疗作用和效果的高度概括。因此物质基础和药理效应是中药药性的两个本质属性。由于中药来源广泛,物质基础复杂,药理效应涉及多种方面,所以一直以来很难找到合适的研究对象和评价方法来研究中药药性。
本课题选取姜黄、郁金为研究对像,是因为二者来源于同一植物的不同药用部位,而二者的寒、热药性却相反,这样使寒、热药性研究更具有针对性和可比性。姜黄为姜科植物姜黄Curcuma longa L.(?)勺根茎,性温,具有破血行气、通经止痛的功能。郁金为姜科植物姜黄Curcuma longa L.的块根,性寒,具有行气化瘀、清心解郁、利胆退黄的功能。
中药的药效物质基础主要来源于植物的次生代谢产物,姜黄、郁金作为同一植物的不同器官所产生的次生代谢产物是否存在差异,差异如何是二者形成寒、热药性的根本原因。因此本研究采用HPLC-DAD-MS和GC-MS分析技术对姜科植物姜黄Curcuma longa L.(?)勺根茎(姜黄)和块根(郁金)的次生代谢产物进行分析,采用模式识别技术对分析结果进行比较,整体上评价二者次生代谢产物的异同,确定生物标志物,从物质基础的角度说明姜黄、郁金形成药性差异的原因。
“寒者热之,热者寒之”是中医药治疗疾病的过程中对中药药性最朴素的认识。姜黄、郁金的寒、热药性是其对不同症候疾病作用后产生效果的高度概括。因此建立与临床相适应的病症模型是评价姜黄、郁金药理效应的前提,而选择合理的评价方法则是阐释二者寒、热药性差异的关键。临床上姜黄、郁金最主要的用药区别是二者分别用于治疗阴黄证(湿寒黄疸)和阳黄证(湿热黄疸)。前期药理实验证明在某些单一指标上(如：黄疸指标、抗氧化指标)姜黄、郁金对两种寒热模型具有不同的治疗效果,但是同时在某些指标上则无法体现二者的差异。为了从不同层次系统地评价姜黄、郁金的药理效应,阐释二者寒、热药性差异,我们尝试采用代谢组学的研究方法整体上评价姜黄、郁金对两种模型的作用效果,比较其异同。
主要研究内容如下：
一、基于代谢组学研究方法的姜黄、郁金植物次生代谢产物差异研究
1.建立了HPLC-DAD-MS分析方法,对姜黄、郁金样品进行了分析。在检测波长265nm下,建立了姜黄、郁金指纹图谱,并采用主成份分析(PCA)对测定结果进行处理,从二维主成份得分图(Scores Polt)可以看到姜黄、郁金样品分别聚为两类,说明二者存在显著差异,主成份载荷图(Loading Plot)为我们提供了造成这种差异的生物标志物群,经过进一步t检验确定了其中10种主要差异代谢产物,通过质谱和紫外数据对其中7种进行了鉴定,并进行了相对含量的比较,姜黄中姜黄素cuncumin,去甲氧基姜黄素Demethoxycurcumin,双去甲氧基姜黄素bisdemethoxycurcumin,双氢姜黄素Dihydrocurcumin,芳姜黄酮Ar-turmerone,姜黄酮a,B-turmerone(或姜黄醇bisacumol),姜烯Zingiberene(或没药烯B-Bisabolene、姜黄烯B-curcumene)的含量均高于郁金。
2.建立GC-MS分析方法,对姜黄、郁金中萜类成分样品进行了分析。样品制备采用石油醚索氏提取,保证了样品制备的重复性。从气质色谱中鉴定了43个化学成分,基于这些成分采用主成份分析(PCA)比较姜黄、郁金二者的差异,从二维主成份得分图(Scores Polt)可以看到姜黄、郁金样品分别聚为两类,说明二者存在显著差异,主成份载荷图(Loading Plot)为我们提供了造成这种差异的生物标志物群,经过进一步t检验确定了其中14种差异代谢产物。
3.通过以上两种分析方法系统地对姜科植物姜黄Curcuma longa L的根茎(姜黄)和块根(郁金)的次生代谢产物进行了分析,发现二者所含化合物的种类基本一致,主要为姜黄素类和萜类化合物；通过模式识别对姜黄、郁金进行了区分,并确定了二者间的差异代谢产物。
二、基于代谢组学的姜黄、郁金寒热药性评价研究
1.针对蛋白质、糖类、脂肪代谢所产生的氨基酸、小分子有机酸、脂肪酸等目标化合物,建立了血浆样品的GC-MS衍生化分析方法。
首先对寒湿黄疸和湿热黄疸(以下分别简称为寒证模型和热证模型)进行代谢轮廓分析,结合有监督(PLS-DA)和无监督(PCA)模式识别数据处理方法,能够实现寒、热模型的识别,并确定了寒、热模型的生物标志物,其中寒证模型组与正常对照组比较,升高的标志物有苏氨酸、甘氨酸等,降低的标志物有半乳糖、柠檬酸等。热证模型组与对照组比较,升高的标志物有苏氨酸、苯丙氨酸、半乳糖、柠檬酸、油酸等,降低的有丁二胺。为进一步评价姜黄、郁金的寒热药性奠定了基础。
针对寒证模型组,我们分析比较了姜黄、郁金、及主要差异代谢产物(姜黄素)干预前后代谢谱的变化。从PLS-DA得分图上,我们可以从整体上看出各组动物代谢谱变化的轨迹。姜黄素组和姜黄组距离寒证模型组距离最远,郁金组与寒证模型组距离较近并有部分重合,说明姜黄、姜黄素对寒证模型代谢谱的调节作用大于郁金,这一点印证了“姜黄性温”中医理论,也说明了姜黄素具有“温性”的药性。并且通过各给药组与寒证模型组间的两两比较,进一步确认了药物作用前后的差异代谢产物,与寒证模型的标志物大部分一致且变化趋势相反。
针对热证模型组,分析比较了姜黄、郁金、姜黄素干预前后代谢谱的的变化。从PLS-DA得分图上,我们可以看到郁金组距热证模型组的距离大于姜黄组。说明郁金对热证模型代谢的影响大于姜黄,反映出郁金具有“寒性”的性质。并且通过各给药组与热证模型组间的两两比较,进一步确认了药物作用前后的差异代谢产物及变化趋势,大部分与热证模型的标志物相一致且变化趋势相反。
2.由于文献报道单胺类神经递质与机体的寒、热状态密切相关,因此针对此类物质,采用HPLC-(ESI)MS,建立了大鼠脑中7种单胺类神经递质代谢物色谱分析方法,并对各组动物进行了分析。
首先对寒、热证模型和正常对照组进行比较,数据处理采用主成份分析,从主成份得分图可以看出正常对照组、寒证模型组,热证模型组分别聚为3类,说明寒、热模型大鼠脑中单胺类神经递质的表达存在差异,经t-test检验,与正常对照组比较E,3-MT,和5—HT含量在热证模型中均有显著升高,寒证模型显著降低。
针对寒证模型,比较了姜黄、郁金、姜黄素对单胺类神经递质表达的影响。经主成份分析姜黄、姜黄素与寒证模型组区分显著,姜黄给药后明显提高了寒证模型中E和5-HT的含量,姜黄素给药后明显提高了寒证模型中E、NE、5-HT,降低了3-MT.而郁金与模型组比较各指标均无显著差异,说明姜黄、姜黄素具有性温的药性。
针对热证模型,比较了姜黄、郁金、姜黄素对单胺类神经递质表达的影响。经主成份分析姜黄、郁金、姜黄素对热证模型均有调节作用。姜黄、郁金给药后降低了热证模型中E、3-MT、5-HT、5-HIAA的含量,进一步比较发现,郁金对上上述指标的降低幅度要大于姜黄；姜黄素给药后与热证模型组在载荷图上有部分重叠,与模型组比较,5-HT降低,DA升高。只是在指标的数量和调节的幅度上,郁金大于姜黄和姜黄素。
3.通过建立以上两种代谢组学分析方法,从不同的角度对湿热黄疸和寒湿黄疸两种寒热模型进行了研究,确定了二者的生物标志物,并在此基础上评价姜黄、郁金、姜黄素对寒、热模型的不同作用,从整体上说明三者作用的差异,进而从代谢组学的角度阐释姜黄、郁金寒、热药性。
本论文的创新点
1、研究对象新颖,可比性强。选择来源于同种植物不同部位的郁金和姜黄为研究对象,两者遗传背景、环境因素相同,且炮制方法相同,尽可能地保证了实验结果的可比性。
2、采用代谢组学的研究方法系统的比较了姜黄、郁金作为同一植物不同部位所含有的次生代谢产物的表达差异,发现相关生物标志物,说明了二者药性差异的物质基础。
3、建立了GC-MS血浆代谢组轮廓分析和HPLC-MS大鼠脑中单胺类神经递质分析的两种代谢组学方法,并将该方法首次应用到姜黄、郁金的药性研究中。通过多元统计分析,确定了湿热黄疸和寒湿黄疸两种寒、热模型的生物标志物,并在此基础上对姜黄、郁金、姜黄素的作用效果进行了评价,从代谢组学的角度阐释了姜黄、郁金的寒、热药性差异,为中药药性的研究提供了新的方法和思路。
The properties of tradional Chinese medicinal herbs, which are the essential basis of the analyses and clinical usage of Chinese medicinal herbs, are summarized in medical practice and on the basis of the theories of Yin-Yang, Hot-Cold,Toxicity and other theories of therapeutic principles of traditional Chinese medicine(TCM).The reason that Chinese medicinal herbs can prevent and treat diseases is due to their two internal natures:chemical components and the biological activities. Because the source of tradional Chinese medicinal herbs is widely, the chemical components were various and the biological activities were related with too many active aspects. So it was lacking the proper methods and objects to study and research the property theory of traditional Chinese medicinal herbs by modern scientific language.
Jianghuang and Yujin which come from the rhizome and tuberous root of Curcuma longa L. are used as two different Chinese medicinal herbs. In the property theory of traditional Chinese medicinal herbs, it was believed that Yujin has cold nature and Jianghuang has hot nature. Accordingly Jianghuang was used to promote circulation of blood and arrest pain while Yujin was used to circulate the blood and normalize the gallbladder and liver to cure jaundice in clinic. As Jianghuang and Yujin come from the same plant of Curcuma longa L, they have similar chemical components and effective activities. So Jianghuang and Yujin were selected as objects, which makes it easier to study and compare the chemical components and the biological activities so as to explain why they have hot and cold nature.
The metabonomics/metabolomics gives a good and new idea to study the plant secondary metabolites and the therapeutic evaluation of TCM. As a part of system biology, metabonomies apply modern chemical analysis technology such as HPLC-MS、GC-MS、NMR to determine active alterations of endogenous metabolites of biological organism and subsequently reveal changes in the whole process, including occurrence, development,and consequences in response to stimuli or drug treatment. Metabonomies, defined as "the quantitative measurement of the multiParametrie time-related metabolic responses of a complex system to a pathophysiological intervention or genetic modification" has been widely used in the researches of pharmacology and biological seiences.
In this thesis firstly we established HPLC-DAD-MS and GC-MS methods to analysis and compare the the plant secondary metabolites of the rhizome(Jianghuang) and tuberous root(Yujin) of Curcuma longa L. Principle Component Analysis(PCA) was used to discovery the biomarkers between Jianghuang and Yujin from chromatograms. Secondly we establish a GC-MS method to analyse plasmar metabolites and a HPLC-MS method to determine brain catecholamine metabolic profiling.With the methods we evaluated the Heat-Syndrome model(damp-heat jaundice model) and Cold-Syndrome model(cold-damp jaundice model). Pattern recognition was used to distinguish Heat-Syndrome model and Cold-Syndrome model. Based on this, we evaluated drug effect of Jianghang,Yujin,and curcumin on Heat-Syndrome model and Cold-Syndrome model. According to different effects on Heat-Syndrome model and Cold-Syndrome model, we can explain and illustrate hot and cold nature of Jianghuang and Yujin.
Main contents are summarized below:
1. The plant secondary metabolites analysis of Jianghang and Yujin by HPLC-DAD-MS and GC-MS.
In order to analyse and compare the the plant secondary metabolites including volatile terpenes and nonvolatile curcuminoids of Jianghuang and Yujin, the metabolite profilings was established by HPLC-DAD-MS and GC-MS.
18 samples of Curcuma longa L inluding the rhizome and tuberous roots were collected from the regions in Sichuan province of China. The samples analyzed by HPLC-DAD-MS were processed by ultrasonic extraction in methanol.While the samples analysed by GC-MS were processed by Soxhlet extraction with light petroleum. After peaks of every chromatograms synchronized, multivariate analysis was performed using the SIMCA-P 12 version (Umetrics AB, Ume□, Sweden) based on the all peak areas(peak area/sample weight). Principal component analysis (PCA) was used and reveal the differences between the the rhizome and tuberous roots.
Form Scores Polts of PCA based on HPLC or GC, there are both obvious difference between Jianghuang and Yujin. Based on chromatograms of HPLC-DAD-MS, there are 10 biomarkers found between Jianghuang and Yujin. Seven of them were identified as Bisdemethoxycurcumin、Demethoxycurcumin、Curcumin Dihydrocurcumin Ar-turmerone、a,β-turmerone (bisacumol)、Zingiberene (B-bisabolene, B-curcumene),which are all higher in Jianghuang than Yujin.Based on chromatograms of GC-MS,14 biomarkers were found and identified whose contents are obvious different between Jianghuang and Yujin.
2. Evaluation of Hot and cold nature of Jianghuang and Yujin by metabonomics method of GC-MS technology
The GC/MS method was established to analyse the blood plasma samples and the Heat-Syndrome model(damp-heat jaundice model) and Cold-Syndrome model(cold-damp jaundice model) rats blood plasma was introdued to GC/MS. Then applying the GC/MS method, the blood plasma samples from the Heat-Syndrome model and Cold-Syndrome model rats treated by Jianghuang、Yujin and curcumin were detected by the machine.With the PCA and PLS-DA, the status of drug effect was evaluated.
With the multianalysis to the metabonomic datas of GC/MS, the Heat-Syndrome group、Cold-Syndrome group and the normal group can be divided into three groups accordingly. And compared with normal group, the biomarkers of the Heat-Syndrome and Cold-Syndrome group were found and identified such as aminoacids, organic acids. Then we compared the efficiency of jianghuang,Yujin and curcumin on the Cold-Syndrome model and the Heat-Syndrome model. The result suggest that Jianghuang and curcumin have more regulation effect on Cold-Syndrome model than Yujin based on the metabonomic datas. While Yujin have more regulation effect on Heat-Syndrome model than Jianghuang and curcumin.
3. Evaluation of Hot and cold nature of Jianghuang and Yujin Based on brain catecholamine Metabolic Profiling
HPLC-MS method for the quantitative determination of 7 catecholamines in brain samples was developed. And Principal Component Analysis(PCA) was processed to analyze the catecholamine metabolic profiling. Heat-Syndrome model and Cold-Syndrome model rats was firstly introdued to HPLC-MS. Then applying the the method, the samples of the Heat-Syndrome model and Cold-Syndrome model rats treated by Jianghuang、Yujin and curcumin were detected.
The results suggest Heat-Syndrome model and Cold-Syndrome model can be distingushed by catecholamine metabolic profiling. Jianghuang、Yujin and curcumin has different effect for the Heat and Cold Syndrome model based on Brain catecholamines Metabolic Profiling.
本课题选取姜黄、郁金为研究对像,是因为二者来源于同一植物的不同药用部位,而二者的寒、热药性却相反,这样使寒、热药性研究更具有针对性和可比性。姜黄为姜科植物姜黄Curcuma longa L.(?)勺根茎,性温,具有破血行气、通经止痛的功能。郁金为姜科植物姜黄Curcuma longa L.的块根,性寒,具有行气化瘀、清心解郁、利胆退黄的功能。
中药的药效物质基础主要来源于植物的次生代谢产物,姜黄、郁金作为同一植物的不同器官所产生的次生代谢产物是否存在差异,差异如何是二者形成寒、热药性的根本原因。因此本研究采用HPLC-DAD-MS和GC-MS分析技术对姜科植物姜黄Curcuma longa L.(?)勺根茎(姜黄)和块根(郁金)的次生代谢产物进行分析,采用模式识别技术对分析结果进行比较,整体上评价二者次生代谢产物的异同,确定生物标志物,从物质基础的角度说明姜黄、郁金形成药性差异的原因。
“寒者热之,热者寒之”是中医药治疗疾病的过程中对中药药性最朴素的认识。姜黄、郁金的寒、热药性是其对不同症候疾病作用后产生效果的高度概括。因此建立与临床相适应的病症模型是评价姜黄、郁金药理效应的前提,而选择合理的评价方法则是阐释二者寒、热药性差异的关键。临床上姜黄、郁金最主要的用药区别是二者分别用于治疗阴黄证(湿寒黄疸)和阳黄证(湿热黄疸)。前期药理实验证明在某些单一指标上(如：黄疸指标、抗氧化指标)姜黄、郁金对两种寒热模型具有不同的治疗效果,但是同时在某些指标上则无法体现二者的差异。为了从不同层次系统地评价姜黄、郁金的药理效应,阐释二者寒、热药性差异,我们尝试采用代谢组学的研究方法整体上评价姜黄、郁金对两种模型的作用效果,比较其异同。
主要研究内容如下：
一、基于代谢组学研究方法的姜黄、郁金植物次生代谢产物差异研究
1.建立了HPLC-DAD-MS分析方法,对姜黄、郁金样品进行了分析。在检测波长265nm下,建立了姜黄、郁金指纹图谱,并采用主成份分析(PCA)对测定结果进行处理,从二维主成份得分图(Scores Polt)可以看到姜黄、郁金样品分别聚为两类,说明二者存在显著差异,主成份载荷图(Loading Plot)为我们提供了造成这种差异的生物标志物群,经过进一步t检验确定了其中10种主要差异代谢产物,通过质谱和紫外数据对其中7种进行了鉴定,并进行了相对含量的比较,姜黄中姜黄素cuncumin,去甲氧基姜黄素Demethoxycurcumin,双去甲氧基姜黄素bisdemethoxycurcumin,双氢姜黄素Dihydrocurcumin,芳姜黄酮Ar-turmerone,姜黄酮a,B-turmerone(或姜黄醇bisacumol),姜烯Zingiberene(或没药烯B-Bisabolene、姜黄烯B-curcumene)的含量均高于郁金。
2.建立GC-MS分析方法,对姜黄、郁金中萜类成分样品进行了分析。样品制备采用石油醚索氏提取,保证了样品制备的重复性。从气质色谱中鉴定了43个化学成分,基于这些成分采用主成份分析(PCA)比较姜黄、郁金二者的差异,从二维主成份得分图(Scores Polt)可以看到姜黄、郁金样品分别聚为两类,说明二者存在显著差异,主成份载荷图(Loading Plot)为我们提供了造成这种差异的生物标志物群,经过进一步t检验确定了其中14种差异代谢产物。
3.通过以上两种分析方法系统地对姜科植物姜黄Curcuma longa L的根茎(姜黄)和块根(郁金)的次生代谢产物进行了分析,发现二者所含化合物的种类基本一致,主要为姜黄素类和萜类化合物；通过模式识别对姜黄、郁金进行了区分,并确定了二者间的差异代谢产物。
二、基于代谢组学的姜黄、郁金寒热药性评价研究
1.针对蛋白质、糖类、脂肪代谢所产生的氨基酸、小分子有机酸、脂肪酸等目标化合物,建立了血浆样品的GC-MS衍生化分析方法。
首先对寒湿黄疸和湿热黄疸(以下分别简称为寒证模型和热证模型)进行代谢轮廓分析,结合有监督(PLS-DA)和无监督(PCA)模式识别数据处理方法,能够实现寒、热模型的识别,并确定了寒、热模型的生物标志物,其中寒证模型组与正常对照组比较,升高的标志物有苏氨酸、甘氨酸等,降低的标志物有半乳糖、柠檬酸等。热证模型组与对照组比较,升高的标志物有苏氨酸、苯丙氨酸、半乳糖、柠檬酸、油酸等,降低的有丁二胺。为进一步评价姜黄、郁金的寒热药性奠定了基础。
针对寒证模型组,我们分析比较了姜黄、郁金、及主要差异代谢产物(姜黄素)干预前后代谢谱的变化。从PLS-DA得分图上,我们可以从整体上看出各组动物代谢谱变化的轨迹。姜黄素组和姜黄组距离寒证模型组距离最远,郁金组与寒证模型组距离较近并有部分重合,说明姜黄、姜黄素对寒证模型代谢谱的调节作用大于郁金,这一点印证了“姜黄性温”中医理论,也说明了姜黄素具有“温性”的药性。并且通过各给药组与寒证模型组间的两两比较,进一步确认了药物作用前后的差异代谢产物,与寒证模型的标志物大部分一致且变化趋势相反。
针对热证模型组,分析比较了姜黄、郁金、姜黄素干预前后代谢谱的的变化。从PLS-DA得分图上,我们可以看到郁金组距热证模型组的距离大于姜黄组。说明郁金对热证模型代谢的影响大于姜黄,反映出郁金具有“寒性”的性质。并且通过各给药组与热证模型组间的两两比较,进一步确认了药物作用前后的差异代谢产物及变化趋势,大部分与热证模型的标志物相一致且变化趋势相反。
2.由于文献报道单胺类神经递质与机体的寒、热状态密切相关,因此针对此类物质,采用HPLC-(ESI)MS,建立了大鼠脑中7种单胺类神经递质代谢物色谱分析方法,并对各组动物进行了分析。
首先对寒、热证模型和正常对照组进行比较,数据处理采用主成份分析,从主成份得分图可以看出正常对照组、寒证模型组,热证模型组分别聚为3类,说明寒、热模型大鼠脑中单胺类神经递质的表达存在差异,经t-test检验,与正常对照组比较E,3-MT,和5—HT含量在热证模型中均有显著升高,寒证模型显著降低。
针对寒证模型,比较了姜黄、郁金、姜黄素对单胺类神经递质表达的影响。经主成份分析姜黄、姜黄素与寒证模型组区分显著,姜黄给药后明显提高了寒证模型中E和5-HT的含量,姜黄素给药后明显提高了寒证模型中E、NE、5-HT,降低了3-MT.而郁金与模型组比较各指标均无显著差异,说明姜黄、姜黄素具有性温的药性。
针对热证模型,比较了姜黄、郁金、姜黄素对单胺类神经递质表达的影响。经主成份分析姜黄、郁金、姜黄素对热证模型均有调节作用。姜黄、郁金给药后降低了热证模型中E、3-MT、5-HT、5-HIAA的含量,进一步比较发现,郁金对上上述指标的降低幅度要大于姜黄；姜黄素给药后与热证模型组在载荷图上有部分重叠,与模型组比较,5-HT降低,DA升高。只是在指标的数量和调节的幅度上,郁金大于姜黄和姜黄素。
3.通过建立以上两种代谢组学分析方法,从不同的角度对湿热黄疸和寒湿黄疸两种寒热模型进行了研究,确定了二者的生物标志物,并在此基础上评价姜黄、郁金、姜黄素对寒、热模型的不同作用,从整体上说明三者作用的差异,进而从代谢组学的角度阐释姜黄、郁金寒、热药性。
本论文的创新点
1、研究对象新颖,可比性强。选择来源于同种植物不同部位的郁金和姜黄为研究对象,两者遗传背景、环境因素相同,且炮制方法相同,尽可能地保证了实验结果的可比性。
2、采用代谢组学的研究方法系统的比较了姜黄、郁金作为同一植物不同部位所含有的次生代谢产物的表达差异,发现相关生物标志物,说明了二者药性差异的物质基础。
3、建立了GC-MS血浆代谢组轮廓分析和HPLC-MS大鼠脑中单胺类神经递质分析的两种代谢组学方法,并将该方法首次应用到姜黄、郁金的药性研究中。通过多元统计分析,确定了湿热黄疸和寒湿黄疸两种寒、热模型的生物标志物,并在此基础上对姜黄、郁金、姜黄素的作用效果进行了评价,从代谢组学的角度阐释了姜黄、郁金的寒、热药性差异,为中药药性的研究提供了新的方法和思路。
The properties of tradional Chinese medicinal herbs, which are the essential basis of the analyses and clinical usage of Chinese medicinal herbs, are summarized in medical practice and on the basis of the theories of Yin-Yang, Hot-Cold,Toxicity and other theories of therapeutic principles of traditional Chinese medicine(TCM).The reason that Chinese medicinal herbs can prevent and treat diseases is due to their two internal natures:chemical components and the biological activities. Because the source of tradional Chinese medicinal herbs is widely, the chemical components were various and the biological activities were related with too many active aspects. So it was lacking the proper methods and objects to study and research the property theory of traditional Chinese medicinal herbs by modern scientific language.
Jianghuang and Yujin which come from the rhizome and tuberous root of Curcuma longa L. are used as two different Chinese medicinal herbs. In the property theory of traditional Chinese medicinal herbs, it was believed that Yujin has cold nature and Jianghuang has hot nature. Accordingly Jianghuang was used to promote circulation of blood and arrest pain while Yujin was used to circulate the blood and normalize the gallbladder and liver to cure jaundice in clinic. As Jianghuang and Yujin come from the same plant of Curcuma longa L, they have similar chemical components and effective activities. So Jianghuang and Yujin were selected as objects, which makes it easier to study and compare the chemical components and the biological activities so as to explain why they have hot and cold nature.
The metabonomics/metabolomics gives a good and new idea to study the plant secondary metabolites and the therapeutic evaluation of TCM. As a part of system biology, metabonomies apply modern chemical analysis technology such as HPLC-MS、GC-MS、NMR to determine active alterations of endogenous metabolites of biological organism and subsequently reveal changes in the whole process, including occurrence, development,and consequences in response to stimuli or drug treatment. Metabonomies, defined as "the quantitative measurement of the multiParametrie time-related metabolic responses of a complex system to a pathophysiological intervention or genetic modification" has been widely used in the researches of pharmacology and biological seiences.
In this thesis firstly we established HPLC-DAD-MS and GC-MS methods to analysis and compare the the plant secondary metabolites of the rhizome(Jianghuang) and tuberous root(Yujin) of Curcuma longa L. Principle Component Analysis(PCA) was used to discovery the biomarkers between Jianghuang and Yujin from chromatograms. Secondly we establish a GC-MS method to analyse plasmar metabolites and a HPLC-MS method to determine brain catecholamine metabolic profiling.With the methods we evaluated the Heat-Syndrome model(damp-heat jaundice model) and Cold-Syndrome model(cold-damp jaundice model). Pattern recognition was used to distinguish Heat-Syndrome model and Cold-Syndrome model. Based on this, we evaluated drug effect of Jianghang,Yujin,and curcumin on Heat-Syndrome model and Cold-Syndrome model. According to different effects on Heat-Syndrome model and Cold-Syndrome model, we can explain and illustrate hot and cold nature of Jianghuang and Yujin.
Main contents are summarized below:
1. The plant secondary metabolites analysis of Jianghang and Yujin by HPLC-DAD-MS and GC-MS.
In order to analyse and compare the the plant secondary metabolites including volatile terpenes and nonvolatile curcuminoids of Jianghuang and Yujin, the metabolite profilings was established by HPLC-DAD-MS and GC-MS.
18 samples of Curcuma longa L inluding the rhizome and tuberous roots were collected from the regions in Sichuan province of China. The samples analyzed by HPLC-DAD-MS were processed by ultrasonic extraction in methanol.While the samples analysed by GC-MS were processed by Soxhlet extraction with light petroleum. After peaks of every chromatograms synchronized, multivariate analysis was performed using the SIMCA-P 12 version (Umetrics AB, Ume□, Sweden) based on the all peak areas(peak area/sample weight). Principal component analysis (PCA) was used and reveal the differences between the the rhizome and tuberous roots.
Form Scores Polts of PCA based on HPLC or GC, there are both obvious difference between Jianghuang and Yujin. Based on chromatograms of HPLC-DAD-MS, there are 10 biomarkers found between Jianghuang and Yujin. Seven of them were identified as Bisdemethoxycurcumin、Demethoxycurcumin、Curcumin Dihydrocurcumin Ar-turmerone、a,β-turmerone (bisacumol)、Zingiberene (B-bisabolene, B-curcumene),which are all higher in Jianghuang than Yujin.Based on chromatograms of GC-MS,14 biomarkers were found and identified whose contents are obvious different between Jianghuang and Yujin.
2. Evaluation of Hot and cold nature of Jianghuang and Yujin by metabonomics method of GC-MS technology
The GC/MS method was established to analyse the blood plasma samples and the Heat-Syndrome model(damp-heat jaundice model) and Cold-Syndrome model(cold-damp jaundice model) rats blood plasma was introdued to GC/MS. Then applying the GC/MS method, the blood plasma samples from the Heat-Syndrome model and Cold-Syndrome model rats treated by Jianghuang、Yujin and curcumin were detected by the machine.With the PCA and PLS-DA, the status of drug effect was evaluated.
With the multianalysis to the metabonomic datas of GC/MS, the Heat-Syndrome group、Cold-Syndrome group and the normal group can be divided into three groups accordingly. And compared with normal group, the biomarkers of the Heat-Syndrome and Cold-Syndrome group were found and identified such as aminoacids, organic acids. Then we compared the efficiency of jianghuang,Yujin and curcumin on the Cold-Syndrome model and the Heat-Syndrome model. The result suggest that Jianghuang and curcumin have more regulation effect on Cold-Syndrome model than Yujin based on the metabonomic datas. While Yujin have more regulation effect on Heat-Syndrome model than Jianghuang and curcumin.
3. Evaluation of Hot and cold nature of Jianghuang and Yujin Based on brain catecholamine Metabolic Profiling
HPLC-MS method for the quantitative determination of 7 catecholamines in brain samples was developed. And Principal Component Analysis(PCA) was processed to analyze the catecholamine metabolic profiling. Heat-Syndrome model and Cold-Syndrome model rats was firstly introdued to HPLC-MS. Then applying the the method, the samples of the Heat-Syndrome model and Cold-Syndrome model rats treated by Jianghuang、Yujin and curcumin were detected.
The results suggest Heat-Syndrome model and Cold-Syndrome model can be distingushed by catecholamine metabolic profiling. Jianghuang、Yujin and curcumin has different effect for the Heat and Cold Syndrome model based on Brain catecholamines Metabolic Profiling.
引文
[1]国家中医药管理局中华本草编委会.中华本草.第8分册[M].上海：上海科技出版社,1999：632—636
[2]郑虎古.中药现代研究与应用[M].北京：学院出版社,1997：3436
[3]G.K. Jayaprakasha, L.JaganMohan Rao, K.K. Sakariah. Chemistry and biological activities of C. longa[J]. Trends in Food Science & Technology,2005,16:533-548
[4]夏文娟,肖小河,苏中武,等.国产姜黄属植物的化学成分分析[J].中国中药杂志,1999,24(7)：423—447
[5]李伟,肖红斌,王龙星,等.高效液相色谱-串联质谱法分析姜黄中微量的姜黄素类化合物[J].色谱,2009,27(3)：264—269
[6]Hongliang Jiang,Barbara N.Timmermanna,David R.Gang. Use of liquid chromatography-electrospray ionization tandem mass spectrometry to identify diarylheptanoids in turmeric(Curcuma longa L.) rhizome[J]. Journal of Chromatography A,2006,1111:21-31
[7]So-Young Park and Darrick S. H. L. Kim. Discovery of Natural Products from Curcuma longa that Protect Cells from Beta-Amyloid Insult:A Drug Discovery Effort against Alzheimer's Disease[J]. Journal of Natural Products,2002,65(9):1227-1231
[8]Kiuchi,F.,Iwakami,S.,Shibuya,M.,Hanaoka,F.,& Sankawa,U.. Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids[J].Chemical and Pharmaceutical Bulletin,1992,40:387-391.
[9]YongChi ZENG,Feng QIU,Kyoko TAKAHASHI,et al. New Sesquiterpenes and Calebin Derivatives from Curcuma longa[J].Chem. Pharm. Bull,2007,55(6):940-943
[10]Kim, D. S. H. L.& Kim,J.Y. Total synthesis of calebin-A,preparation of its analogues, and their neuronal cell protectivity against b-amyloid insult[J]. Bioorganic and Medicinal Chemistry Letters,2001,11:2541-2543.
[11]Araujo,C.A.C.,Alegrio,et al. Studies on the effectiveness of diarylheptanoids derivatives against Leishmania amazonensis[J].Memorias do Instituto Oswaldo Cruz,1999,94:791-794.
[12]Claeson,P.,Pongprayoon,U.,Sematong,et al. Non-phenolic linear diarylheptanoids from Curcuma xanthorrhiza:A novel type of topical anti-inflammatory agents:Structure activity relationship[J].Planta Medica,1996,62:236-240.
[13]陈晋红,李伟荣,刘大伟,等.姜黄药材中有效成分含量测定[J].中药新药与临床药理,2009,5(30)：253—255
[14]葛跃伟,高慧敏,王智民.姜黄属药用植物研究进展[J].中国中药杂志,2007,32(23)：2461—2467
[15]Malingre,T.R. Curcuma xanthorrhiza roxb.,temoe lawak,als plant met galdrijrende werking[J]. Pharmaceutisch Weekblad,1975,110,601-606.
[16]王丽瑶,张勉,张朝风,王峥涛.黄丝郁金中的生物碱和倍半萜类成分[J].药学学报,2008,43(7)：724—727
[17]曾永篪,梁键谋,曲戈霞,邱峰.姜黄的化学成分研究Ⅰ：没药烷型倍半萜[J].中国药物化学杂志,2007,17(4)：238—239
[18]Wei Li, Jia-Tao Feng, Yuan-Sheng Xiao,et al. Three novel terpenoids from the rhizomes of Curcuma longa[J]. Journal of Asian Natural Products Research, Vol.00, No.0,2009,1-7
[19]N.Y. Qin, F.Q. Yang, Y.T. Wang, S.P. Li. Quantitative determination of eight components in rhizome (Jianghuang) and tuberous root (Yujin) of Curcuma longa using pressurized liquid extraction and gas chromatography-mass spectrometry[J]. Journal of Pharmaceutical and Biomedical Analysis,2007,43:486-492
[20]Kojima,H.,Yanai,T.,Toyota,A.,Hanani,E.,& Saiki,Y.(1998).Essential oil constituents from Curcuma aromatica, C. longa and C. xanthorrhiza rhizomes. In H. Ageta, N. Aimi, Y. Ebizaka, T.Fujita,& G. Honda (Eds.), Towards natural medicine research in the 21st century (pp. 531-539). Amsterdam:Elsevier.
[21]刘红星,陈福北,黄初升,何冬梅.从姜黄及姜黄浸膏中提取的挥发油化学成分研究.分析测试学报[J],2007,26(增刊)：146—148
[22]陈毓亨,余竞光,方洪钜.我国姜黄属植物的研究Ⅲ.姜黄Curcuma longa根茎和块根挥发油和酚性成分的比较.中药通报,1983,8(1)：27—29.
[23]Nigam,M.C.& Ahmed,A. Curcuma longa:Terpenoid composition of its essential oil[J].Indian Perfumer,1991,3:201-205.
[24]张萍,张桂芝,樊晴月,张立.GC-MS法分析姜黄饮片挥发油的特征性化学成分.现代中药研究与实践,2008,22(3)：41—44
[25]吴惠勤,张桂英,史志强,肖润.超临界C02萃取姜油及其成分的GC/MS分析[J].质谱学报,21(3/4)：85—87
[26]胡永狮,杜青云,汤秋华.气相色谱-质谱法测定姜黄挥发油化学成分[J].色谱,1998,16(6)：528—530
[27]唐课文,陈国斌.气相色谱-质谱法分析姜黄挥发油化学成分[J].质谱学报,2004,25(3)：163—165
[28]汤敏燕,汪洪武,孙凌峰.中药姜黄挥发油化学成分研究[J].江西师范大学学报,2000,24(3)：274—276
[29]刘春燕.姜黄的化学成分研究[D].沈阳：沈阳药科大学,硕十论文,2008.
[30]Masashi Tomoda, Ryoko Gonda, Noriko Shimizu,et al. A reticuloendothelial system activating glycan from the rhizomes of Curcuma longa[J]. Phytochemistry,1990,29(4):1083-1086
[31]张浩,谢成科,焦文旭.中药郁金中姜黄素类成分及微量元素分析[J].天然产物研究与开发,1997(4)：37—40
[32]易进海,陈燕,李伯刚,等.郁金化学成分的研究[J].天然产物研究与开发,2003,15(2)：98.
[33]Majeed,M.,Badmaev,V.,Shivakumar,U.,&Rajendran,R(1995).Curcuminoids-antioxidant phytonutrients. Piscataway, NJ:Nutriscience Publishers, Inc.
[34]Gonda R,Tomoda M,Shimizu N,Kanari M. Characterization of polysaccharides having activity on the reticuloendothelial system from the rhizome of Curcuma longa[J]. Chem Pharm Bull,1990,38(2):482-486.
[35]Srivastava KC,Bordia A,Verma SK.Curcumin,a major component of food spice turmeric(Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets.Prostaglandins -Leukot-Essent- Fatty-Acids,1995,52(4):223
[36]吴树荣.姜黄素对大鼠血小板聚集和抗血栓形成的影响军.军医进修学院学报,1996,17(1)：31-33
[37]Yegnanarayan R et al. Indian J Med Res,1976;64:601
[38]Srimal RC et al.J Pharm Pharmacol,1973;25(6):447-452
[39]Ammon, H.P.T, Wahl, M.A姜黄的药理研究(摘要).中药药理与临床1992；8(3)：47
[40]韩婷,必鹤鸣.姜黄的化学成分及药理活性研究进展.解放军药学学报,2001,17(2)：95-96
[41]Ramirez-Tortosa MC,Mesa MD,Aguilera MC,et al.Oral administr-ation of a turmeric extract inhibitsLDL oxidation and has hypocholeste-rolemic effects in rabbits with experimental atterosclerosis[J].Atherosclerosis,1999,147(2):37
[42]沃兴德,等.姜黄素对高脂血症作用的实验研究.浙江中西医结合杂志,1994,3(1)：24
[43]As A, M lyaZawa T. Dietary curcuminoids Prevent high-fatdiet induced lip-id acumulation in rat liver and epididymal adipose tissue.Nutr,2001,131(11):2932-35
[44]刘永刚,陈厚昌,蒋毅萍,等.姜黄素抗肝纤维化的实验研究.时珍国医国药,2002,13(5)：27
[45]Ammon, H.P.T, Wahl, M.A姜黄的药理研究(摘要).中药药理与临床1992；8(3)：47
[46]朱晓薇.姜黄的药理作用.国外医药·植物药分册,1999,14(2)：57
[47]陈华,薛常镐,陈铁辉,等.姜黄及姜黄素对微囊藻粗毒素致急性肝损伤的化学预防作用.中国药理学通报,2005,21(12)：1517-1519.
[48]孙军,李岩.姜黄素对人肝癌细胞BEL-7402中HIF-1表达的影响.中国药理学通报,2006,22(11)：1379-1383.
[49]马海清,许林锋.姜黄素抗血管生成作用及在肝癌介入治疗中的应用前景.国外医学：临床放射学分册,2006,29(6)：412-415.
[50]石雪蓉,顾健,谭睿.姜黄挥发油抗肿瘤作用机制研究.中药药理与临床,2003,19(6)：15-16
[51]吴裕丹,陈燕,陈文娟,等.姜黄素对急性髓性白血病细胞HL-60增殖和凋亡的影响.同济医科大学学报,1999,28(4)：299
[52]许建华,赵蓉,吴国士,等.姜黄素的抗肿瘤作用.中药药理与临床,1998,14(3)：15
[53]石晶,田亚平.姜黄素对小鼠血浆、脑及肝脏超氧化物歧化酶和脂质过氧化物含量的影响.军医进修学院学报,1996,17(3)：206
[54]石晶,顾军,邓心新,等.姜黄素对大鼠心肌缺血性损伤的保护作用.中国药理学通报,1995,14(2)：14
[55]赵革平,等.姜黄醇提取物对抗体外LDL氧化修饰作用的研究.浙江中医学院学报,1999,23(4)：27-28.
[56]谭华,李作孝,李小红,等.加用姜黄素对脑梗死患者血浆超氧化物歧化酶及丙二醛的 影响.中国中西医结合杂志,2003,23(2)：110-111.
[57]曹煜；周先宝.姜科姜黄属植物挥发油抗真菌实验研究.贵阳医学院学报,1988,2
[58]李诚秀,李玲,罗俊,等.姜黄挥发油对呼吸道作用的研究.中国中药杂志,1998,23(10)：624
[59]朱晓薇.姜黄的药理作用.国外医药·植物药分册,1999,14(2)：57
[60]陈文星；刘乐平；李磷；陆茵；程光；李宁.姜黄素抗抑郁作用及其机理研究.中药新药与临床药理,2006,17(5)：317-320
[61]国家中医药管理局《中华本草》编委会.中华本草精选本(下册).上海：上海科学技术出版社,1998.2279
[62]国家药典委员会.中华人民共和国药典2005年版一部.北京：化学工业出版社,2005.144
[63]张浩,谢成科,焦文旭.中药郁金的挥发油成分研究.天然产物研究与开发,1997,9(1)：28.
[64]李艳萍.中药郁金的化学成分研究.西北大学学报,2000,30(5)：411-414.
[65]夏文娟,肖小河,刘峰群,等.国产姜黄属植物的化学成分分析.中国中药杂志,1999,24(7)：423
[66]彭炳先,周欣,王道平,等.HPLC法测定姜黄、莪术、郁金中三种姜黄色素的含量.中药材,2004,27(11)：813—815
[67]张安将,张示列,张力学.温郁金中生物碱的初步分离和鉴定[J].温州师范学院学报：自然科学版,1999,20(3)：44-46.
[68]张浩,谢成科,焦文旭.中药郁金中姜黄素类成分及微量元素分析[J].天然产物研究与开发,1997,9(4)：37-40
[69]李敏,唐远,付福友,等.郁金的研究进展.世界科学技术—中医药现代化,2004,6(2)：35
[70]段文卓,宫海民.丹参、红花、郁金对红细胞功能的影响.山东中医药大学学报,1997,21(2)：138—139
[71]段文卓,宫海民.红花、郁金对血管平滑肌细胞表型及增殖变化的影响.中国病理生理杂志,2000,16(10)：979
[72]郭淑睿,曹永荣,高光英.郁金对实验性高脂血症动物血.脂含量的影响[J].中医药研究,1998,14(3)：32.
[73]张伟荣.温郁金注射液对CC14代谢物与肝微粒体脂质和蛋白质共价结合的抑制作用研究[J].中医药学报,1990(2)：46.
[74]贾宽,杨保华,梁德年,等.郁金挥发油对小鼠中毒性肝炎模型免疫功能的影响.中国免疫学杂志,1989,5(2)：121—123
[75]汪龙德,李红芳.单味郁金对离体兔奥狄氏括约肌、胆囊和十二指肠平滑肌活动的影响.甘肃中医学院学报,2002,19(2)：14—15
[76]曲雷鸣,龚伟.复方郁金片抗肿瘤实验研究.辽宁中医药大学学报,2007,9(3)：35
[77]王佳林,吕宾,倪桂宝,等.温郁金对VEGF和MVD在人胃癌裸小鼠移植瘤中表达的研究.肿瘤,2005,25(1)：55.
[78]徐毅,吕宾,丁志山,等.不同温郁金提取物抑制胃癌细胞SGC-7901增殖和诱导凋亡的实验研究.浙江医学,2001,26(7)：503-505
[79]郝洪谦,孙兵,郑开俊,等.郁金二酮对家猫睡眠节律电活动的调制作用.中草 药,1994,28(5)：423
[80]杨淑娟,郑天珍,瞿颂义.郁金对胃平滑肌条运动的影响.宁波大学学报(理工版),2004,1(2)：227—229
[81]张寅恭,蔡宁加,沈康元.温郁金对动物的终止妊娠作用.中成药研究,1983,6：29—30
[82]王滨,曹军.温郁金提取液对辐射所致脂类过氧化的影响.哈尔滨医科大学学报.1996,30(2)：128
[83]王滨,周丽,牛淑冬,等.温郁金提取液在辐射损伤过程中对抗氧化酶活力的影响.中医药学报,2000(2)：74—75
[1]高晓山.中药药性论[M].北京：人民卫生出版社,1992,11
[2]贺福元,邓凯文,罗杰英,李博,贺庆平,刘文龙.中药四性研究现状与设想.中国实验方剂学杂志,2008,14(8)：72-75
[3]关正戚,等.病位与寒热辩证因子.日本东洋医学杂志,1989,40(1)：51
[4]梁月华,谢竹藩.中医寒热本质的初步研究[J].中华医学杂志,1979,59(2)：705
[5]梁月华,孙尚拱.植物神经平衡的综合指标测定法[J].北京医学院学报,1979,4：239
[6]梁月华,李薪萍,任红.寒证热证时中枢、内脏、尿内儿茶酚胺及5-羟色胺的变化.中医杂志,1991,12：38—40
[7]梁月华,等.寒凉药与温热药对交感神经及代谢机能的影响.北京医科大学学报1987；19(1)：54.
[8]梁月华,王传社,章云津.寒凉药与温热药复方及知母对交感神经系统的作用机制探讨.中药通报,1988；13(11)：48.
[9]杨鸿志,梁月华,任红.温热药(附子、干姜、肉桂)复方及小复方对交感神经系、肾上腺、TSH、LH等的影响.中国中药杂志,1992；17(11)：688.
[10]谢竹藩.从尿中儿茶酚胺及cAMP、cGMP的排出量探讨中医寒证、热证的本质.中西医结合杂志,1986,6(1)：651—654.
[11]郭宇光,谢竹藩.虚寒证、虚热证患者尿PGE2、PGF2a排出量的临床观察.中西医结合杂志,1990,10(10)：593—595.
[12]杨勇,梁月华,汪长中,等.虚寒、虚热证大鼠神经、内分泌、免疫与血液流变学的时相性研究.中国中医基础医学杂志,2002,8(2)：29-32.
[13]周志东,王学敏,缪明勇等.“寒体”、“热体”大鼠肝线粒体能量代谢的研究.上海中医药大学学报,2000,14(2)：34—37
[14]陈群,刘亚梅,徐志伟,等.实热证、虚热证模型大鼠肝细胞琥珀酸脱氢酶活性研究.北京中医药大学学报,2000,23(5)：48-49
[15]王米渠,冯韧,严石林,等.5例寒证的宏观疗效及基因表达谱芯片分析研究.浙江中医学院学报,2003,27(6)：60—63
[16]吴斌,杨丽萍,张天娥,等.热药疗寒的基因表达谱研究.中国中药杂志,2006,31(11)：914
[17]黄丽萍,彭淑红,蒙晓芳,等.6种寒性中药对大鼠肝脏能量代谢的影响.中国中药杂志,2009,34(24)：3255-58
[18]黄丽萍,彭淑红,胡强,等.6味热性中药对大鼠骨骼肌能量代谢相关因子的影响.中华中医药杂志,2010,25(2)：228-230
[19]朱荣林,杨秋秀.寒热中药微量元素的比较与分析.广东微量元素科学,1995,2(8)：17
[20]胡育筑,郭环娟,王志群.中药四性和微量元素含量关系的初步研究.中国药科大学学报,1992,23(6)：348-353.
[21]陈和利,冯江,孙龙川,等.100种中药的四性与15种无机元素含量关系的研究.微量元素与健康研究,1996,13(4)：33-34.
[22]臧梓因.中药化学成分与其药性关系浅析.中国中医药信息杂志,2003,10(11)：75.
[23]李健,李峰,王厚伟.中药药性与蛋白质含量相关性研究.山东中医药大学学报,2009,33(3)：181-183
[24]周正礼,李峰,李佳.20种中药总糖含量与寒热药性关系探讨.山东中医药大学学报,2009,33(1)：5—8
[25]翟华强,张冰,艾明要,等.基于复杂系统的中药药性理论研究思考,北京中医药大学学报,2008,31(8)：522—524
[26]刘树民,卢芳.基于系统生转学阐释中药药性理论科学内涵的研究思路与方法探讨,世界科学技术一中医药现代化,2008,12(2)：12—16
[27]刘家强,江津河.中药药性理论的基因组研究.中医药学刊2006,24(11)：2092—2093.
[28]余惠旻,肖小河,刘塔斯,等.中药四性的生物热动力学研究(Ⅰ)生晒参和红参药性的微量量热学比较.中国中药杂志,2002,27(5)：393
[29]周韶华,潘五九,肖小河,等.中药四性的生物热动力学研究—黄连不同炮制品药性的微量热学比较.中草药,2004,35(11)：1230
[30]周韶华,肖小河,赵艳玲,等.中药四性的生物热动力学研究—左金丸与反左金寒热药性的微量热学比较.中国中药杂志,2004,29(12)：1183
[31]樊冬丽,鄢丹,廖庆文,等.基于生物热力学表达的麻黄汤和麻杏石甘汤的寒热药性比较.中国中药杂志,2007,32(5)：421-424
[32]谢宗万.关于中药品种与性效关系的探讨.中医药学报,1990,(6)：34-37.
[33]何光华.种仁类中药性能特点辨析.四川中医,2005,23(10)：43-44.
[34]侯永春,赵宏,孙龙川.浅析藤茎类药性能特点.江西中医药,2004,35(3)：58-59.
[35]刘辉,孙文平,杨光,等.以果实入药的中药药性分析.中国中医药信息杂志,2005,12(11)：40-41
[1]Nicholson JK,Bollard ME,Lindon JC,Holmes E. Metabonomics:a platform for studying drug toxicity and gene function[J].Drug Discovery 2002,1:153-162
[2]K Tanaka, A West-Dull, DG Hine, TB Lynn and T Lowe. Gas-chromatographic method of analysis for urinary organic acids. Ⅱ. Description of the procedure, and its application to diagnosis of patients with organic acidurias. Clinical Chemistry,1980,26(13):1847-1853
[3]Devaux PG, HorningMG, HorningEC.Benyzl-oximederivative of steroids:a new metabolic profile procedure for human urinary steroids. Anal Lett,1971,4:151
[4]Gates SC,Sweeley CC. Quantitative metabolic profiling based on gas chromatography[J].Clin Chem.1978,24:1663-1673.
[5]Fiehn O.Metabolic networks of Cucurbita maxima phloem.Phytochemistry,2003,62(6):875
[6]Fiehn O.Link between genotypes and phenotypes. Plant Mol Biol,2002,48(2):155
[7]TaylorJ,KingRD,AltmannT, etal. Application of metabolomics to plant genotype discrimination using statistics and machine learning. Bio informatics,2002,18(3):241
[8]HallR, BealeM, Fiehn O.,etal. Plantmetabolomics:the missing link in functional genomics strategies. PlantCell,2002,14(7):1437
[9]Nicholson JK, Lindon JC, Holmes E. Metabonomics:understanding the metabolic responses of living systems to pathophysi-ological stimuli via muhi-variate statistical analysis of biological NMR spectroscopic data. Xenobiotica.1999,29(11):1181
[10]GennanJB, BaumanDE, BurrrinDG, etal.Metabolomics in the opening decade of the 21st century:building the roads to individualized health. J Nutn,2004,134(10):2729
[11]Fiehn O. Combininggenomics, metabolome analysis, and biochemical modelling to understand metabolic networks.Comparative and Functional Genomics,2001,2:155-168
[12]王斯婷,李晓娜,王皎,凌笑梅.代谢组学及其分析技术.药物分析杂志,2010,30(9)：1792-1799
[13]许国旺,路鑫,杨胜利.代谢组学研究进展.中国医学科学院学报,2007,29(6)：701
[14]Oliver Fiehn, Joachim Kopka, Peter Dormann, Thomas Altmann, Richard N. Trethewey,and Lothar Willmitzer. Metabolite profiling forplant functional genomics. NATURE BIOTECHNOLOGY 2000, Vol 18:1157-1161
[15]Fiehn, O., Kopka, J., Trethewey, R.N.& Willmitzer, L. Identification of uncommon plant metabolites based on calculation of elemental compositions using gas chromatography and quadrupole mass spectrometry. Anal. Chem.2000,72,3573-3580
[16]Roeijmans,H.J.;De Hoog,G.S.;Tan,C.S.;Figge, M.J., Molecular taxonomy and GC/MS of metabolites of Scytalidium hyalinum and Nattrassia mangiferae(Hendersonula toruloidea).J Med VetMycol 1997,35,(3),181-188.
[17]黄欣,龚益飞,王毅,瞿海斌,程翼宇.代谢组学方法研究水飞蓟宾对四氯化碳致小鼠肝损伤的保护作用.高等学校化学学报,2008,29(4)：719-718
[18]Roessner U,Wagner C,Kopka J,Trethewey Rn,Willmitzer L.Technical advance:simultaneous analysis of metabolites in potato tuber by gas chromatography mass spectrometry[J].Plant J.2000,23：131-142.
[19]樊夏雷,刘文英,王广基,等.基于GC-TOF-MS的关木通肾毒性代谢组学研究.毒理学杂志,2007,21(4)：323
[20]陆益红,王广基,黄青,等.自发性高血压大鼠血浆代谢组学研究及人参总皂苷作用机制初探.中国天然药物,2007,5(6)：443
[21]Yang J, Xu G, ZhengY, KongH, Wang C, ZhaoX, PangT.J. Chromatogr. A,2005,1084(1-2): 214-221
[22]Yang J, Xu G, ZhengY, KongH, PangT, Lv S, YangQ.J. Chromatogr. B,2004,813(1-2):59-65
[23]Yang J, Xu G, KongH, ZhengY, PangT, YangQ.J. Chromatogr. B,2002,780(1):27-33
[24]汪江山,赵欣捷,郑育芳,等.超高效液相色谱-飞行时间质谱用于人参皂苷Rg3作用后大鼠尿液代谢物指纹图谱分析及标记物的鉴定.色谱,2006,24(1)：5
[25]卢果,汪江山,赵欣捷,等.超高效液相色谱-飞行时间质谱法分析尿液中的代谢物用于区分人类性别的研究.色谱,2006,24(2)：109
[26]W illiamsR E, Lenz EM, Evans JA, W ilson ID, Granger JH, Plumb R S, StumpfC L.J. Pharm. Biomed. Anal.,2005,38(3):465-471
[27]沈朋,康宇飞,程翼宇.乳腺癌代谢物组模式特征发现方法及HPLC/MS/MS分析.高等学校化学学,2005,26(10)：1798
[28]陈艳华,张瑞萍,宋咏梅,等.基于RRLC-MS/MS方法的恶性肿瘤代谢组学研究.分析化学,2009,37(A03)：22
[29]Lauridsen MB, Bliddal H, Christensen R, Danneskiold-Samsφe B, Bennett R, Keun H, Lindon JC, Nicholson JK, Dorff MH, Jaroszewski JW, Hansen SH, Cornett C.1HNMR spectroscopy-based interventional metabolic phenotyping:a cohort study of rheumatoid arthritis patients. J Proteome Res.2010 Sep 3;9(9):4545-53
[30]Lindon JC,Nicholson JK,Holmes E,Antti H,Bollard ME,Keun H,Beckonert O,Ebbels TM,Reily MD,Robertson D,Stevens GJ,Luke P,Cantor GH,Bible RH,Niederhauser U,Senn H,Schlotterbeck G,Sidelmann UG,Laursen SM, Tymiak A,Car BD,Lehman-McKeeman L,Colet JM,Loukaci A,Thomas C. Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project[J].Toxicol Appl Pharm.2003,187:137-146.
[31]Brindle JT, Antti H, Holmes Eet al. Rapid and noninvasive diagnosis ofthe presence and severity of coronary heart disease using 1HNMR-based metabonomics.Nat Med,2002,8(12): 1439-1444
[32]刘霞,肖瑛,高红吕,任进,林东海.基于1HNMR代谢组学方法分析马兜铃酸Ⅰ诱导的雌雄小鼠急性肾毒性.高等学校化学学报,2010,31(5)：927-932
[33]Ellis D I,Broadhurst D,Kell DB,et al. Rapid and quantitative detection of the microbial spoilage of meat by fourier transform infrared spectroscopy and machine learning.Appl EnvironMicrobiol,2002,68(6):2822-2828
[34]Johnson HE, Broadhurst D, Goodacre R, Smith AR.Metabolic fingerprinting of salt-stressed tomatoes. Phyto-chemistry,2003,62(6):919-928
[35]Helen E. Johnson,David Broadhurst, Douglas B. Kell,et al. High-Throughput Metabolic Fingerprinting of Legume Silage Fermentations via Fourier Transform Infrared Spectroscopy and Chemometrics. Phyto-chemistry,2004,70(3):1583-1592
[36]Ramautar R, Dem irci A, De Jong GJ. Capillary electrophoresis in metabolomics Trends Analyt Chem,2006,25(5):455-465.
[37]阳平.毛细管电泳质谱联用技术及其在代谢组学研究中的应用.生物技术通报,2010,(8)：57-63
[38]Edwards JL, Ch iso 1m CN, Shackm an JG, et al.Negative mode sheath less capillary electrophoresis electrospray ionization-mass spectrometry for metabolite analysis of prokaryotes. J Chromatogr A,2006,1106(12):80-88.
[39]Kaiser T, Wittke S, Just I, et al. Capillary electrophores is coupled to mass spectrometer for automated and robust polypeptide determination in body fluids for clinical use. Electrophores is,2004,25(13):2044-2055
[40]卢红梅,梁逸曾.代谢组学分析技术及数据处理技术.分析测试学报,2008,27(3)：325-332
[41]任洪灿,王广基,阿基业,等代谢组学分析技术平台和数据处理的新进展.中药临床药理学与治疗学,2007,12(12)：1332-1338
[42]张琪,王广基,杜宇,相秉仁,邓海山,阿基业,马博.几种模式识别方法在大鼠高脂血症代谢组学研究中的应用.中国药科大学学报,2009,40(5)：448-454
[43]阿基业.代谢组学数据处理方法---主成分分析.中药临床药理学与治疗学,2010,15(5)：482-489
[44]王广基,阿基业,严蓓,郝海平,刘林生,张颖,顾胜华,郑媛婷.代谢组学研究冠心病中医分型的体内物质基础.世界科学技术—中医药现代化,2009,11(1)：127-133
[45]朱萱萱,王广基,阿基业,管恩泽,严蓓。冠心病中医辨证分型的代谢组学研究.中华中医药学刊,2009,27(6)：1267-1268
[46]罗和古,丁杰,岳广欣,等.大鼠肝郁脾虚证的代谢组学研究.中西医结合学报,2007,5(3)：307—313
[47]陈冬梅,杜慧兰.虚寒证的证候规律及其代谢组学的研究.河北医科大学博士学位论文2008
[48]Li Lin,Wang JN,Ren JX,et al.Metabonomics analysis of the urine of rats with Qideficiency and blood stasis syndrome based on NMR techniques.中国科学通报(英文 版),2007,52(22):3068-3073.
[49]蒋宁,周文霞,张永祥.应用代谢组学方法研究比较六味及八味地黄汤的作用机制[J].中药药理与临床,2007,23(5)：451
[50]赵剑宁,颜贤忠,彭双清.利用代谢组学技术研究中药关木通的肾毒性作用[J]世界科学技术-中医药现代化,2007,9(5)：54-59.
[51]赵剑宇,颜贤忠,彭双清.关木通肾毒性的代谢组学研究[J]中草药,2006,37(05)：725-730
[52]王喜军,孙文军,孙晖,等.CCL4诱导大鼠肝损伤模型的代谢组学及菌陈蒿汤的干预作用 研究.世界科学技术-中医药现代化,2006,8：101-103.
[53]罗和古,陈家旭,岳广欣,等.逍遥散调节慢性束缚应激大鼠代谢组学的实验研究[J].中国中西医结合杂志,2008,28(12)：1112-1117.
[1]国家药典委员会.中华人民共和国药典版(一部)[S],北京：化学工业出版社,2005：187
[2]郑虎古.中药现代研究与应用[M].北京：学院出版社,1997：3436
[3]夏文娟,肖小河,苏中武,等.国产姜黄属植物的化学成分分析[J].中国中药杂志,1999.24(7)：423—447
[4]Hongliang Jiang, Arpad Somogyi, Neil E. Jacobsen, Barbara N.Timmermann and David R. Gang. Analysis of curcuminoids by positive and negative electrospray ionization and tandem mass spectrometry. Rapid Commun. Mass Spectrom,2006,20:1001-1012
[5]Hongliang Jiang, Barbara N.Timmermanna, David R. Gang. Use of liquid chromatography-electrospray ionization tandem mass spectrometry to identify diarylheptanoids in turmeric(Curcuma longa L.) rhizome. Journal of Chromatography A, 2006 (1111):21-31
[6]李伟,肖红斌,王龙星,梁鑫淼.高效液相色谱-串联质谱法分析姜黄中微量的姜黄素类化合物.2009,27(3)：264-269
[7]Xian-Guo He, Long-Ze Lin, Li-Zhi Lian, Michael Lindenmaier. Liquid chromatography-electrospray mass spectrometric analysis of curcuminoids and sesquiterpenoids in turmeric (Curcuma longa). Journal of Chromatography A,818 (1998) 127-132
[8]Ammon, H.P.T, Wahl, M.A姜黄的药理研究(摘要).中药药理与临床1992；8(3)：47
[9]葛跃伟,高慧敏,王智民.姜黄属药用植物研究进展[J].中国中药杂志,2007,32(23)：2461-2467
[1]国家药典委员会.中华人民共和国药典2010年版一部.北京：化学工业出版社,2010：247,193
[2]李洪梅.药性·药效·成分的相关性——郁金和姜黄之研究[D].北京：中国中医科学院,博士论文,2010.
[3]曲长江,吴谙诏,王文丽,等.茵陈术附汤对中医阴黄证黄疸动物模型影响的实验研究.辽宁中医学院学报,2006,8(1)：89—90
[4]曲长江,吴谙诏,王文丽,等.茵陈蒿汤对中医阳黄证黄疸动物模型影响的实验研究.中医药学刊,2005,23(10)：1808—1809
[5]朱嘉,方祝元.代谢组学与中医“证”的相关性.现代中西医结合杂志,2009,18(8)：938-941
[6]国家药典委员会.中华人民共和国药典2010年版一部.北京：化学工业出版社,2010：245
[7]黄欣,龚益飞,王毅,瞿海斌,程翼宇.代谢组学方法研究水飞蓟宾对四氯化碳致小鼠肝损伤的保护作用.高等化学学报,2008,29(4)：714-719
[8]严蓓,阿基业,郝海平,等.心血.瘀阻与气阴两虚证心肌缺血大鼠模型的代谢组学表征与辨识.中国科学,2008,38(12)：1143-1151
[9]樊夏雷,刘文英,王广基,等.基于GC-TOF-MS(?)勺关木通肾毒性代谢组学研究.毒理学杂志,2007,21(4)：323
[10]盛国平.基于GC-MS和LC-MS的肝病代谢组学研究[D].浙江：浙江大学,博士论文,2008.
[11]梁月华,等.中医寒热本质的初步研究.中华医学杂志,1979,59(12)：705
[12]梁月华,等.寒凉药与温热药对交感神经及代谢机能的影响.北京医科大学学报1987；19(1)：54.
[13]杨鸿志,梁月华,任红.温热药(附子、干姜、肉桂)复方及小复方对交感神经系、肾上腺、TSH、LH等的影响.中国中药杂志,1992；17(11)：688.
[14]顾群,石先哲,许国旺.生物样品中儿茶酚胺类物质分析方法的研究进展.色谱,2007,25(4)：457—462
[15]Mark M. Kushnir, Francis M. Urry, Elizabeth L. Frank, William L. Roberts.and Bori Shushan. Analysis of Catecholamines in Urine by Positive-Ion Electrospray Tandem Mass Spectrometry. Clinical Chemistry 48:2323-331 (2002)
[16]Tornkvist A, Sjoberg PJ, Markides KE, Bergquist J. Analysis of catecholamines and related substances using porous graphitic carbon as separation media in liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci.2004 Mar 5;801(2):323-9.
[17]梁月华,李薪萍,任红.寒证热证时中枢—内脏—尿内儿茶酚胺及5—羟色胺的变化.中医杂志,1991,(12)：38—40
[18]梁月华.寒热本质研究进展.中医杂志,1996,37(12)：747—750
[19]李良、刘国桢、梁月华.寒凉和温热药对大鼠脑-垂体和肾上腺内5-羟色胺及去甲肾上腺素神经元和纤维的影响.中国中药杂志,1999,24(2)：360—362
[2]郑虎古.中药现代研究与应用[M].北京：学院出版社,1997：3436
[3]G.K. Jayaprakasha, L.JaganMohan Rao, K.K. Sakariah. Chemistry and biological activities of C. longa[J]. Trends in Food Science & Technology,2005,16:533-548
[4]夏文娟,肖小河,苏中武,等.国产姜黄属植物的化学成分分析[J].中国中药杂志,1999,24(7)：423—447
[5]李伟,肖红斌,王龙星,等.高效液相色谱-串联质谱法分析姜黄中微量的姜黄素类化合物[J].色谱,2009,27(3)：264—269
[6]Hongliang Jiang,Barbara N.Timmermanna,David R.Gang. Use of liquid chromatography-electrospray ionization tandem mass spectrometry to identify diarylheptanoids in turmeric(Curcuma longa L.) rhizome[J]. Journal of Chromatography A,2006,1111:21-31
[7]So-Young Park and Darrick S. H. L. Kim. Discovery of Natural Products from Curcuma longa that Protect Cells from Beta-Amyloid Insult:A Drug Discovery Effort against Alzheimer's Disease[J]. Journal of Natural Products,2002,65(9):1227-1231
[8]Kiuchi,F.,Iwakami,S.,Shibuya,M.,Hanaoka,F.,& Sankawa,U.. Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids[J].Chemical and Pharmaceutical Bulletin,1992,40:387-391.
[9]YongChi ZENG,Feng QIU,Kyoko TAKAHASHI,et al. New Sesquiterpenes and Calebin Derivatives from Curcuma longa[J].Chem. Pharm. Bull,2007,55(6):940-943
[10]Kim, D. S. H. L.& Kim,J.Y. Total synthesis of calebin-A,preparation of its analogues, and their neuronal cell protectivity against b-amyloid insult[J]. Bioorganic and Medicinal Chemistry Letters,2001,11:2541-2543.
[11]Araujo,C.A.C.,Alegrio,et al. Studies on the effectiveness of diarylheptanoids derivatives against Leishmania amazonensis[J].Memorias do Instituto Oswaldo Cruz,1999,94:791-794.
[12]Claeson,P.,Pongprayoon,U.,Sematong,et al. Non-phenolic linear diarylheptanoids from Curcuma xanthorrhiza:A novel type of topical anti-inflammatory agents:Structure activity relationship[J].Planta Medica,1996,62:236-240.
[13]陈晋红,李伟荣,刘大伟,等.姜黄药材中有效成分含量测定[J].中药新药与临床药理,2009,5(30)：253—255
[14]葛跃伟,高慧敏,王智民.姜黄属药用植物研究进展[J].中国中药杂志,2007,32(23)：2461—2467
[15]Malingre,T.R. Curcuma xanthorrhiza roxb.,temoe lawak,als plant met galdrijrende werking[J]. Pharmaceutisch Weekblad,1975,110,601-606.
[16]王丽瑶,张勉,张朝风,王峥涛.黄丝郁金中的生物碱和倍半萜类成分[J].药学学报,2008,43(7)：724—727
[17]曾永篪,梁键谋,曲戈霞,邱峰.姜黄的化学成分研究Ⅰ：没药烷型倍半萜[J].中国药物化学杂志,2007,17(4)：238—239
[18]Wei Li, Jia-Tao Feng, Yuan-Sheng Xiao,et al. Three novel terpenoids from the rhizomes of Curcuma longa[J]. Journal of Asian Natural Products Research, Vol.00, No.0,2009,1-7
[19]N.Y. Qin, F.Q. Yang, Y.T. Wang, S.P. Li. Quantitative determination of eight components in rhizome (Jianghuang) and tuberous root (Yujin) of Curcuma longa using pressurized liquid extraction and gas chromatography-mass spectrometry[J]. Journal of Pharmaceutical and Biomedical Analysis,2007,43:486-492
[20]Kojima,H.,Yanai,T.,Toyota,A.,Hanani,E.,& Saiki,Y.(1998).Essential oil constituents from Curcuma aromatica, C. longa and C. xanthorrhiza rhizomes. In H. Ageta, N. Aimi, Y. Ebizaka, T.Fujita,& G. Honda (Eds.), Towards natural medicine research in the 21st century (pp. 531-539). Amsterdam:Elsevier.
[21]刘红星,陈福北,黄初升,何冬梅.从姜黄及姜黄浸膏中提取的挥发油化学成分研究.分析测试学报[J],2007,26(增刊)：146—148
[22]陈毓亨,余竞光,方洪钜.我国姜黄属植物的研究Ⅲ.姜黄Curcuma longa根茎和块根挥发油和酚性成分的比较.中药通报,1983,8(1)：27—29.
[23]Nigam,M.C.& Ahmed,A. Curcuma longa:Terpenoid composition of its essential oil[J].Indian Perfumer,1991,3:201-205.
[24]张萍,张桂芝,樊晴月,张立.GC-MS法分析姜黄饮片挥发油的特征性化学成分.现代中药研究与实践,2008,22(3)：41—44
[25]吴惠勤,张桂英,史志强,肖润.超临界C02萃取姜油及其成分的GC/MS分析[J].质谱学报,21(3/4)：85—87
[26]胡永狮,杜青云,汤秋华.气相色谱-质谱法测定姜黄挥发油化学成分[J].色谱,1998,16(6)：528—530
[27]唐课文,陈国斌.气相色谱-质谱法分析姜黄挥发油化学成分[J].质谱学报,2004,25(3)：163—165
[28]汤敏燕,汪洪武,孙凌峰.中药姜黄挥发油化学成分研究[J].江西师范大学学报,2000,24(3)：274—276
[29]刘春燕.姜黄的化学成分研究[D].沈阳：沈阳药科大学,硕十论文,2008.
[30]Masashi Tomoda, Ryoko Gonda, Noriko Shimizu,et al. A reticuloendothelial system activating glycan from the rhizomes of Curcuma longa[J]. Phytochemistry,1990,29(4):1083-1086
[31]张浩,谢成科,焦文旭.中药郁金中姜黄素类成分及微量元素分析[J].天然产物研究与开发,1997(4)：37—40
[32]易进海,陈燕,李伯刚,等.郁金化学成分的研究[J].天然产物研究与开发,2003,15(2)：98.
[33]Majeed,M.,Badmaev,V.,Shivakumar,U.,&Rajendran,R(1995).Curcuminoids-antioxidant phytonutrients. Piscataway, NJ:Nutriscience Publishers, Inc.
[34]Gonda R,Tomoda M,Shimizu N,Kanari M. Characterization of polysaccharides having activity on the reticuloendothelial system from the rhizome of Curcuma longa[J]. Chem Pharm Bull,1990,38(2):482-486.
[35]Srivastava KC,Bordia A,Verma SK.Curcumin,a major component of food spice turmeric(Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets.Prostaglandins -Leukot-Essent- Fatty-Acids,1995,52(4):223
[36]吴树荣.姜黄素对大鼠血小板聚集和抗血栓形成的影响军.军医进修学院学报,1996,17(1)：31-33
[37]Yegnanarayan R et al. Indian J Med Res,1976;64:601
[38]Srimal RC et al.J Pharm Pharmacol,1973;25(6):447-452
[39]Ammon, H.P.T, Wahl, M.A姜黄的药理研究(摘要).中药药理与临床1992；8(3)：47
[40]韩婷,必鹤鸣.姜黄的化学成分及药理活性研究进展.解放军药学学报,2001,17(2)：95-96
[41]Ramirez-Tortosa MC,Mesa MD,Aguilera MC,et al.Oral administr-ation of a turmeric extract inhibitsLDL oxidation and has hypocholeste-rolemic effects in rabbits with experimental atterosclerosis[J].Atherosclerosis,1999,147(2):37
[42]沃兴德,等.姜黄素对高脂血症作用的实验研究.浙江中西医结合杂志,1994,3(1)：24
[43]As A, M lyaZawa T. Dietary curcuminoids Prevent high-fatdiet induced lip-id acumulation in rat liver and epididymal adipose tissue.Nutr,2001,131(11):2932-35
[44]刘永刚,陈厚昌,蒋毅萍,等.姜黄素抗肝纤维化的实验研究.时珍国医国药,2002,13(5)：27
[45]Ammon, H.P.T, Wahl, M.A姜黄的药理研究(摘要).中药药理与临床1992；8(3)：47
[46]朱晓薇.姜黄的药理作用.国外医药·植物药分册,1999,14(2)：57
[47]陈华,薛常镐,陈铁辉,等.姜黄及姜黄素对微囊藻粗毒素致急性肝损伤的化学预防作用.中国药理学通报,2005,21(12)：1517-1519.
[48]孙军,李岩.姜黄素对人肝癌细胞BEL-7402中HIF-1表达的影响.中国药理学通报,2006,22(11)：1379-1383.
[49]马海清,许林锋.姜黄素抗血管生成作用及在肝癌介入治疗中的应用前景.国外医学：临床放射学分册,2006,29(6)：412-415.
[50]石雪蓉,顾健,谭睿.姜黄挥发油抗肿瘤作用机制研究.中药药理与临床,2003,19(6)：15-16
[51]吴裕丹,陈燕,陈文娟,等.姜黄素对急性髓性白血病细胞HL-60增殖和凋亡的影响.同济医科大学学报,1999,28(4)：299
[52]许建华,赵蓉,吴国士,等.姜黄素的抗肿瘤作用.中药药理与临床,1998,14(3)：15
[53]石晶,田亚平.姜黄素对小鼠血浆、脑及肝脏超氧化物歧化酶和脂质过氧化物含量的影响.军医进修学院学报,1996,17(3)：206
[54]石晶,顾军,邓心新,等.姜黄素对大鼠心肌缺血性损伤的保护作用.中国药理学通报,1995,14(2)：14
[55]赵革平,等.姜黄醇提取物对抗体外LDL氧化修饰作用的研究.浙江中医学院学报,1999,23(4)：27-28.
[56]谭华,李作孝,李小红,等.加用姜黄素对脑梗死患者血浆超氧化物歧化酶及丙二醛的 影响.中国中西医结合杂志,2003,23(2)：110-111.
[57]曹煜；周先宝.姜科姜黄属植物挥发油抗真菌实验研究.贵阳医学院学报,1988,2
[58]李诚秀,李玲,罗俊,等.姜黄挥发油对呼吸道作用的研究.中国中药杂志,1998,23(10)：624
[59]朱晓薇.姜黄的药理作用.国外医药·植物药分册,1999,14(2)：57
[60]陈文星；刘乐平；李磷；陆茵；程光；李宁.姜黄素抗抑郁作用及其机理研究.中药新药与临床药理,2006,17(5)：317-320
[61]国家中医药管理局《中华本草》编委会.中华本草精选本(下册).上海：上海科学技术出版社,1998.2279
[62]国家药典委员会.中华人民共和国药典2005年版一部.北京：化学工业出版社,2005.144
[63]张浩,谢成科,焦文旭.中药郁金的挥发油成分研究.天然产物研究与开发,1997,9(1)：28.
[64]李艳萍.中药郁金的化学成分研究.西北大学学报,2000,30(5)：411-414.
[65]夏文娟,肖小河,刘峰群,等.国产姜黄属植物的化学成分分析.中国中药杂志,1999,24(7)：423
[66]彭炳先,周欣,王道平,等.HPLC法测定姜黄、莪术、郁金中三种姜黄色素的含量.中药材,2004,27(11)：813—815
[67]张安将,张示列,张力学.温郁金中生物碱的初步分离和鉴定[J].温州师范学院学报：自然科学版,1999,20(3)：44-46.
[68]张浩,谢成科,焦文旭.中药郁金中姜黄素类成分及微量元素分析[J].天然产物研究与开发,1997,9(4)：37-40
[69]李敏,唐远,付福友,等.郁金的研究进展.世界科学技术—中医药现代化,2004,6(2)：35
[70]段文卓,宫海民.丹参、红花、郁金对红细胞功能的影响.山东中医药大学学报,1997,21(2)：138—139
[71]段文卓,宫海民.红花、郁金对血管平滑肌细胞表型及增殖变化的影响.中国病理生理杂志,2000,16(10)：979
[72]郭淑睿,曹永荣,高光英.郁金对实验性高脂血症动物血.脂含量的影响[J].中医药研究,1998,14(3)：32.
[73]张伟荣.温郁金注射液对CC14代谢物与肝微粒体脂质和蛋白质共价结合的抑制作用研究[J].中医药学报,1990(2)：46.
[74]贾宽,杨保华,梁德年,等.郁金挥发油对小鼠中毒性肝炎模型免疫功能的影响.中国免疫学杂志,1989,5(2)：121—123
[75]汪龙德,李红芳.单味郁金对离体兔奥狄氏括约肌、胆囊和十二指肠平滑肌活动的影响.甘肃中医学院学报,2002,19(2)：14—15
[76]曲雷鸣,龚伟.复方郁金片抗肿瘤实验研究.辽宁中医药大学学报,2007,9(3)：35
[77]王佳林,吕宾,倪桂宝,等.温郁金对VEGF和MVD在人胃癌裸小鼠移植瘤中表达的研究.肿瘤,2005,25(1)：55.
[78]徐毅,吕宾,丁志山,等.不同温郁金提取物抑制胃癌细胞SGC-7901增殖和诱导凋亡的实验研究.浙江医学,2001,26(7)：503-505
[79]郝洪谦,孙兵,郑开俊,等.郁金二酮对家猫睡眠节律电活动的调制作用.中草 药,1994,28(5)：423
[80]杨淑娟,郑天珍,瞿颂义.郁金对胃平滑肌条运动的影响.宁波大学学报(理工版),2004,1(2)：227—229
[81]张寅恭,蔡宁加,沈康元.温郁金对动物的终止妊娠作用.中成药研究,1983,6：29—30
[82]王滨,曹军.温郁金提取液对辐射所致脂类过氧化的影响.哈尔滨医科大学学报.1996,30(2)：128
[83]王滨,周丽,牛淑冬,等.温郁金提取液在辐射损伤过程中对抗氧化酶活力的影响.中医药学报,2000(2)：74—75
[1]高晓山.中药药性论[M].北京：人民卫生出版社,1992,11
[2]贺福元,邓凯文,罗杰英,李博,贺庆平,刘文龙.中药四性研究现状与设想.中国实验方剂学杂志,2008,14(8)：72-75
[3]关正戚,等.病位与寒热辩证因子.日本东洋医学杂志,1989,40(1)：51
[4]梁月华,谢竹藩.中医寒热本质的初步研究[J].中华医学杂志,1979,59(2)：705
[5]梁月华,孙尚拱.植物神经平衡的综合指标测定法[J].北京医学院学报,1979,4：239
[6]梁月华,李薪萍,任红.寒证热证时中枢、内脏、尿内儿茶酚胺及5-羟色胺的变化.中医杂志,1991,12：38—40
[7]梁月华,等.寒凉药与温热药对交感神经及代谢机能的影响.北京医科大学学报1987；19(1)：54.
[8]梁月华,王传社,章云津.寒凉药与温热药复方及知母对交感神经系统的作用机制探讨.中药通报,1988；13(11)：48.
[9]杨鸿志,梁月华,任红.温热药(附子、干姜、肉桂)复方及小复方对交感神经系、肾上腺、TSH、LH等的影响.中国中药杂志,1992；17(11)：688.
[10]谢竹藩.从尿中儿茶酚胺及cAMP、cGMP的排出量探讨中医寒证、热证的本质.中西医结合杂志,1986,6(1)：651—654.
[11]郭宇光,谢竹藩.虚寒证、虚热证患者尿PGE2、PGF2a排出量的临床观察.中西医结合杂志,1990,10(10)：593—595.
[12]杨勇,梁月华,汪长中,等.虚寒、虚热证大鼠神经、内分泌、免疫与血液流变学的时相性研究.中国中医基础医学杂志,2002,8(2)：29-32.
[13]周志东,王学敏,缪明勇等.“寒体”、“热体”大鼠肝线粒体能量代谢的研究.上海中医药大学学报,2000,14(2)：34—37
[14]陈群,刘亚梅,徐志伟,等.实热证、虚热证模型大鼠肝细胞琥珀酸脱氢酶活性研究.北京中医药大学学报,2000,23(5)：48-49
[15]王米渠,冯韧,严石林,等.5例寒证的宏观疗效及基因表达谱芯片分析研究.浙江中医学院学报,2003,27(6)：60—63
[16]吴斌,杨丽萍,张天娥,等.热药疗寒的基因表达谱研究.中国中药杂志,2006,31(11)：914
[17]黄丽萍,彭淑红,蒙晓芳,等.6种寒性中药对大鼠肝脏能量代谢的影响.中国中药杂志,2009,34(24)：3255-58
[18]黄丽萍,彭淑红,胡强,等.6味热性中药对大鼠骨骼肌能量代谢相关因子的影响.中华中医药杂志,2010,25(2)：228-230
[19]朱荣林,杨秋秀.寒热中药微量元素的比较与分析.广东微量元素科学,1995,2(8)：17
[20]胡育筑,郭环娟,王志群.中药四性和微量元素含量关系的初步研究.中国药科大学学报,1992,23(6)：348-353.
[21]陈和利,冯江,孙龙川,等.100种中药的四性与15种无机元素含量关系的研究.微量元素与健康研究,1996,13(4)：33-34.
[22]臧梓因.中药化学成分与其药性关系浅析.中国中医药信息杂志,2003,10(11)：75.
[23]李健,李峰,王厚伟.中药药性与蛋白质含量相关性研究.山东中医药大学学报,2009,33(3)：181-183
[24]周正礼,李峰,李佳.20种中药总糖含量与寒热药性关系探讨.山东中医药大学学报,2009,33(1)：5—8
[25]翟华强,张冰,艾明要,等.基于复杂系统的中药药性理论研究思考,北京中医药大学学报,2008,31(8)：522—524
[26]刘树民,卢芳.基于系统生转学阐释中药药性理论科学内涵的研究思路与方法探讨,世界科学技术一中医药现代化,2008,12(2)：12—16
[27]刘家强,江津河.中药药性理论的基因组研究.中医药学刊2006,24(11)：2092—2093.
[28]余惠旻,肖小河,刘塔斯,等.中药四性的生物热动力学研究(Ⅰ)生晒参和红参药性的微量量热学比较.中国中药杂志,2002,27(5)：393
[29]周韶华,潘五九,肖小河,等.中药四性的生物热动力学研究—黄连不同炮制品药性的微量热学比较.中草药,2004,35(11)：1230
[30]周韶华,肖小河,赵艳玲,等.中药四性的生物热动力学研究—左金丸与反左金寒热药性的微量热学比较.中国中药杂志,2004,29(12)：1183
[31]樊冬丽,鄢丹,廖庆文,等.基于生物热力学表达的麻黄汤和麻杏石甘汤的寒热药性比较.中国中药杂志,2007,32(5)：421-424
[32]谢宗万.关于中药品种与性效关系的探讨.中医药学报,1990,(6)：34-37.
[33]何光华.种仁类中药性能特点辨析.四川中医,2005,23(10)：43-44.
[34]侯永春,赵宏,孙龙川.浅析藤茎类药性能特点.江西中医药,2004,35(3)：58-59.
[35]刘辉,孙文平,杨光,等.以果实入药的中药药性分析.中国中医药信息杂志,2005,12(11)：40-41
[1]Nicholson JK,Bollard ME,Lindon JC,Holmes E. Metabonomics:a platform for studying drug toxicity and gene function[J].Drug Discovery 2002,1:153-162
[2]K Tanaka, A West-Dull, DG Hine, TB Lynn and T Lowe. Gas-chromatographic method of analysis for urinary organic acids. Ⅱ. Description of the procedure, and its application to diagnosis of patients with organic acidurias. Clinical Chemistry,1980,26(13):1847-1853
[3]Devaux PG, HorningMG, HorningEC.Benyzl-oximederivative of steroids:a new metabolic profile procedure for human urinary steroids. Anal Lett,1971,4:151
[4]Gates SC,Sweeley CC. Quantitative metabolic profiling based on gas chromatography[J].Clin Chem.1978,24:1663-1673.
[5]Fiehn O.Metabolic networks of Cucurbita maxima phloem.Phytochemistry,2003,62(6):875
[6]Fiehn O.Link between genotypes and phenotypes. Plant Mol Biol,2002,48(2):155
[7]TaylorJ,KingRD,AltmannT, etal. Application of metabolomics to plant genotype discrimination using statistics and machine learning. Bio informatics,2002,18(3):241
[8]HallR, BealeM, Fiehn O.,etal. Plantmetabolomics:the missing link in functional genomics strategies. PlantCell,2002,14(7):1437
[9]Nicholson JK, Lindon JC, Holmes E. Metabonomics:understanding the metabolic responses of living systems to pathophysi-ological stimuli via muhi-variate statistical analysis of biological NMR spectroscopic data. Xenobiotica.1999,29(11):1181
[10]GennanJB, BaumanDE, BurrrinDG, etal.Metabolomics in the opening decade of the 21st century:building the roads to individualized health. J Nutn,2004,134(10):2729
[11]Fiehn O. Combininggenomics, metabolome analysis, and biochemical modelling to understand metabolic networks.Comparative and Functional Genomics,2001,2:155-168
[12]王斯婷,李晓娜,王皎,凌笑梅.代谢组学及其分析技术.药物分析杂志,2010,30(9)：1792-1799
[13]许国旺,路鑫,杨胜利.代谢组学研究进展.中国医学科学院学报,2007,29(6)：701
[14]Oliver Fiehn, Joachim Kopka, Peter Dormann, Thomas Altmann, Richard N. Trethewey,and Lothar Willmitzer. Metabolite profiling forplant functional genomics. NATURE BIOTECHNOLOGY 2000, Vol 18:1157-1161
[15]Fiehn, O., Kopka, J., Trethewey, R.N.& Willmitzer, L. Identification of uncommon plant metabolites based on calculation of elemental compositions using gas chromatography and quadrupole mass spectrometry. Anal. Chem.2000,72,3573-3580
[16]Roeijmans,H.J.;De Hoog,G.S.;Tan,C.S.;Figge, M.J., Molecular taxonomy and GC/MS of metabolites of Scytalidium hyalinum and Nattrassia mangiferae(Hendersonula toruloidea).J Med VetMycol 1997,35,(3),181-188.
[17]黄欣,龚益飞,王毅,瞿海斌,程翼宇.代谢组学方法研究水飞蓟宾对四氯化碳致小鼠肝损伤的保护作用.高等学校化学学报,2008,29(4)：719-718
[18]Roessner U,Wagner C,Kopka J,Trethewey Rn,Willmitzer L.Technical advance:simultaneous analysis of metabolites in potato tuber by gas chromatography mass spectrometry[J].Plant J.2000,23：131-142.
[19]樊夏雷,刘文英,王广基,等.基于GC-TOF-MS的关木通肾毒性代谢组学研究.毒理学杂志,2007,21(4)：323
[20]陆益红,王广基,黄青,等.自发性高血压大鼠血浆代谢组学研究及人参总皂苷作用机制初探.中国天然药物,2007,5(6)：443
[21]Yang J, Xu G, ZhengY, KongH, Wang C, ZhaoX, PangT.J. Chromatogr. A,2005,1084(1-2): 214-221
[22]Yang J, Xu G, ZhengY, KongH, PangT, Lv S, YangQ.J. Chromatogr. B,2004,813(1-2):59-65
[23]Yang J, Xu G, KongH, ZhengY, PangT, YangQ.J. Chromatogr. B,2002,780(1):27-33
[24]汪江山,赵欣捷,郑育芳,等.超高效液相色谱-飞行时间质谱用于人参皂苷Rg3作用后大鼠尿液代谢物指纹图谱分析及标记物的鉴定.色谱,2006,24(1)：5
[25]卢果,汪江山,赵欣捷,等.超高效液相色谱-飞行时间质谱法分析尿液中的代谢物用于区分人类性别的研究.色谱,2006,24(2)：109
[26]W illiamsR E, Lenz EM, Evans JA, W ilson ID, Granger JH, Plumb R S, StumpfC L.J. Pharm. Biomed. Anal.,2005,38(3):465-471
[27]沈朋,康宇飞,程翼宇.乳腺癌代谢物组模式特征发现方法及HPLC/MS/MS分析.高等学校化学学,2005,26(10)：1798
[28]陈艳华,张瑞萍,宋咏梅,等.基于RRLC-MS/MS方法的恶性肿瘤代谢组学研究.分析化学,2009,37(A03)：22
[29]Lauridsen MB, Bliddal H, Christensen R, Danneskiold-Samsφe B, Bennett R, Keun H, Lindon JC, Nicholson JK, Dorff MH, Jaroszewski JW, Hansen SH, Cornett C.1HNMR spectroscopy-based interventional metabolic phenotyping:a cohort study of rheumatoid arthritis patients. J Proteome Res.2010 Sep 3;9(9):4545-53
[30]Lindon JC,Nicholson JK,Holmes E,Antti H,Bollard ME,Keun H,Beckonert O,Ebbels TM,Reily MD,Robertson D,Stevens GJ,Luke P,Cantor GH,Bible RH,Niederhauser U,Senn H,Schlotterbeck G,Sidelmann UG,Laursen SM, Tymiak A,Car BD,Lehman-McKeeman L,Colet JM,Loukaci A,Thomas C. Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project[J].Toxicol Appl Pharm.2003,187:137-146.
[31]Brindle JT, Antti H, Holmes Eet al. Rapid and noninvasive diagnosis ofthe presence and severity of coronary heart disease using 1HNMR-based metabonomics.Nat Med,2002,8(12): 1439-1444
[32]刘霞,肖瑛,高红吕,任进,林东海.基于1HNMR代谢组学方法分析马兜铃酸Ⅰ诱导的雌雄小鼠急性肾毒性.高等学校化学学报,2010,31(5)：927-932
[33]Ellis D I,Broadhurst D,Kell DB,et al. Rapid and quantitative detection of the microbial spoilage of meat by fourier transform infrared spectroscopy and machine learning.Appl EnvironMicrobiol,2002,68(6):2822-2828
[34]Johnson HE, Broadhurst D, Goodacre R, Smith AR.Metabolic fingerprinting of salt-stressed tomatoes. Phyto-chemistry,2003,62(6):919-928
[35]Helen E. Johnson,David Broadhurst, Douglas B. Kell,et al. High-Throughput Metabolic Fingerprinting of Legume Silage Fermentations via Fourier Transform Infrared Spectroscopy and Chemometrics. Phyto-chemistry,2004,70(3):1583-1592
[36]Ramautar R, Dem irci A, De Jong GJ. Capillary electrophoresis in metabolomics Trends Analyt Chem,2006,25(5):455-465.
[37]阳平.毛细管电泳质谱联用技术及其在代谢组学研究中的应用.生物技术通报,2010,(8)：57-63
[38]Edwards JL, Ch iso 1m CN, Shackm an JG, et al.Negative mode sheath less capillary electrophoresis electrospray ionization-mass spectrometry for metabolite analysis of prokaryotes. J Chromatogr A,2006,1106(12):80-88.
[39]Kaiser T, Wittke S, Just I, et al. Capillary electrophores is coupled to mass spectrometer for automated and robust polypeptide determination in body fluids for clinical use. Electrophores is,2004,25(13):2044-2055
[40]卢红梅,梁逸曾.代谢组学分析技术及数据处理技术.分析测试学报,2008,27(3)：325-332
[41]任洪灿,王广基,阿基业,等代谢组学分析技术平台和数据处理的新进展.中药临床药理学与治疗学,2007,12(12)：1332-1338
[42]张琪,王广基,杜宇,相秉仁,邓海山,阿基业,马博.几种模式识别方法在大鼠高脂血症代谢组学研究中的应用.中国药科大学学报,2009,40(5)：448-454
[43]阿基业.代谢组学数据处理方法---主成分分析.中药临床药理学与治疗学,2010,15(5)：482-489
[44]王广基,阿基业,严蓓,郝海平,刘林生,张颖,顾胜华,郑媛婷.代谢组学研究冠心病中医分型的体内物质基础.世界科学技术—中医药现代化,2009,11(1)：127-133
[45]朱萱萱,王广基,阿基业,管恩泽,严蓓。冠心病中医辨证分型的代谢组学研究.中华中医药学刊,2009,27(6)：1267-1268
[46]罗和古,丁杰,岳广欣,等.大鼠肝郁脾虚证的代谢组学研究.中西医结合学报,2007,5(3)：307—313
[47]陈冬梅,杜慧兰.虚寒证的证候规律及其代谢组学的研究.河北医科大学博士学位论文2008
[48]Li Lin,Wang JN,Ren JX,et al.Metabonomics analysis of the urine of rats with Qideficiency and blood stasis syndrome based on NMR techniques.中国科学通报(英文 版),2007,52(22):3068-3073.
[49]蒋宁,周文霞,张永祥.应用代谢组学方法研究比较六味及八味地黄汤的作用机制[J].中药药理与临床,2007,23(5)：451
[50]赵剑宁,颜贤忠,彭双清.利用代谢组学技术研究中药关木通的肾毒性作用[J]世界科学技术-中医药现代化,2007,9(5)：54-59.
[51]赵剑宇,颜贤忠,彭双清.关木通肾毒性的代谢组学研究[J]中草药,2006,37(05)：725-730
[52]王喜军,孙文军,孙晖,等.CCL4诱导大鼠肝损伤模型的代谢组学及菌陈蒿汤的干预作用 研究.世界科学技术-中医药现代化,2006,8：101-103.
[53]罗和古,陈家旭,岳广欣,等.逍遥散调节慢性束缚应激大鼠代谢组学的实验研究[J].中国中西医结合杂志,2008,28(12)：1112-1117.
[1]国家药典委员会.中华人民共和国药典版(一部)[S],北京：化学工业出版社,2005：187
[2]郑虎古.中药现代研究与应用[M].北京：学院出版社,1997：3436
[3]夏文娟,肖小河,苏中武,等.国产姜黄属植物的化学成分分析[J].中国中药杂志,1999.24(7)：423—447
[4]Hongliang Jiang, Arpad Somogyi, Neil E. Jacobsen, Barbara N.Timmermann and David R. Gang. Analysis of curcuminoids by positive and negative electrospray ionization and tandem mass spectrometry. Rapid Commun. Mass Spectrom,2006,20:1001-1012
[5]Hongliang Jiang, Barbara N.Timmermanna, David R. Gang. Use of liquid chromatography-electrospray ionization tandem mass spectrometry to identify diarylheptanoids in turmeric(Curcuma longa L.) rhizome. Journal of Chromatography A, 2006 (1111):21-31
[6]李伟,肖红斌,王龙星,梁鑫淼.高效液相色谱-串联质谱法分析姜黄中微量的姜黄素类化合物.2009,27(3)：264-269
[7]Xian-Guo He, Long-Ze Lin, Li-Zhi Lian, Michael Lindenmaier. Liquid chromatography-electrospray mass spectrometric analysis of curcuminoids and sesquiterpenoids in turmeric (Curcuma longa). Journal of Chromatography A,818 (1998) 127-132
[8]Ammon, H.P.T, Wahl, M.A姜黄的药理研究(摘要).中药药理与临床1992；8(3)：47
[9]葛跃伟,高慧敏,王智民.姜黄属药用植物研究进展[J].中国中药杂志,2007,32(23)：2461-2467
[1]国家药典委员会.中华人民共和国药典2010年版一部.北京：化学工业出版社,2010：247,193
[2]李洪梅.药性·药效·成分的相关性——郁金和姜黄之研究[D].北京：中国中医科学院,博士论文,2010.
[3]曲长江,吴谙诏,王文丽,等.茵陈术附汤对中医阴黄证黄疸动物模型影响的实验研究.辽宁中医学院学报,2006,8(1)：89—90
[4]曲长江,吴谙诏,王文丽,等.茵陈蒿汤对中医阳黄证黄疸动物模型影响的实验研究.中医药学刊,2005,23(10)：1808—1809
[5]朱嘉,方祝元.代谢组学与中医“证”的相关性.现代中西医结合杂志,2009,18(8)：938-941
[6]国家药典委员会.中华人民共和国药典2010年版一部.北京：化学工业出版社,2010：245
[7]黄欣,龚益飞,王毅,瞿海斌,程翼宇.代谢组学方法研究水飞蓟宾对四氯化碳致小鼠肝损伤的保护作用.高等化学学报,2008,29(4)：714-719
[8]严蓓,阿基业,郝海平,等.心血.瘀阻与气阴两虚证心肌缺血大鼠模型的代谢组学表征与辨识.中国科学,2008,38(12)：1143-1151
[9]樊夏雷,刘文英,王广基,等.基于GC-TOF-MS(?)勺关木通肾毒性代谢组学研究.毒理学杂志,2007,21(4)：323
[10]盛国平.基于GC-MS和LC-MS的肝病代谢组学研究[D].浙江：浙江大学,博士论文,2008.
[11]梁月华,等.中医寒热本质的初步研究.中华医学杂志,1979,59(12)：705
[12]梁月华,等.寒凉药与温热药对交感神经及代谢机能的影响.北京医科大学学报1987；19(1)：54.
[13]杨鸿志,梁月华,任红.温热药(附子、干姜、肉桂)复方及小复方对交感神经系、肾上腺、TSH、LH等的影响.中国中药杂志,1992；17(11)：688.
[14]顾群,石先哲,许国旺.生物样品中儿茶酚胺类物质分析方法的研究进展.色谱,2007,25(4)：457—462
[15]Mark M. Kushnir, Francis M. Urry, Elizabeth L. Frank, William L. Roberts.and Bori Shushan. Analysis of Catecholamines in Urine by Positive-Ion Electrospray Tandem Mass Spectrometry. Clinical Chemistry 48:2323-331 (2002)
[16]Tornkvist A, Sjoberg PJ, Markides KE, Bergquist J. Analysis of catecholamines and related substances using porous graphitic carbon as separation media in liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci.2004 Mar 5;801(2):323-9.
[17]梁月华,李薪萍,任红.寒证热证时中枢—内脏—尿内儿茶酚胺及5—羟色胺的变化.中医杂志,1991,(12)：38—40
[18]梁月华.寒热本质研究进展.中医杂志,1996,37(12)：747—750
[19]李良、刘国桢、梁月华.寒凉和温热药对大鼠脑-垂体和肾上腺内5-羟色胺及去甲肾上腺素神经元和纤维的影响.中国中药杂志,1999,24(2)：360—362
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |